RP HPLC method development and validation for simultaneous determination of trifluridine and tipiracil in pure and tablet dosage form

Authors

  • RV. Valli Kumari Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical sciences, Maisammaguda, Dhulapally, Secundrabad -500014,Telangana State, India.
  • G. Vardhani Department of Pharmaceutical Analysis, Malla Reddy Institute of Pharmaceutical sciences, Maisammaguda, Dhulapally, Secundrabad -500014,Telangana State, India.

DOI:

https://doi.org/10.61096/ijpar.v8.iss3.2019.377-386

Keywords:

Trifluridine, Tipiracil, RP-HPLC, Validation.

Abstract

In this research, Lonsurf Tablets (strength:Trifluridine 20mg and Tipiracil 8.19mg) was investigated for trifluridine and tipiracil content by isocratic RP-HPLC Procedure. Potent separation with reproducible resolution of trifluridine and tipiracil was brought using acetonitrile (35%) and 0.1M dipotassium hydrogen phosphate (65%) at 1.0ml/min rate of flow. 10 µl and 265 nm are the sample injection volume and wavelength set for detection and analysis , respectively. The procedure was validated and favourable linearity of Trifluridine (10 to 30 µg/ml) and Tipiracil (4.095 to 12.285 µg/ml) was achieved with regression coefficient of 0.9999 and 0.9998, respectively. The proposed procedure of RP-HPLC proved to be suitable, rapid, accurate, precise, selective and robust for partition and assessment of Trifluridine and Tipiracil in tablets in quality control labs.

Downloads

Published

2022-09-13

How to Cite

RV. Valli Kumari, & G. Vardhani. (2022). RP HPLC method development and validation for simultaneous determination of trifluridine and tipiracil in pure and tablet dosage form. IJPAR JOURNAL, 8(3), 377–386. https://doi.org/10.61096/ijpar.v8.iss3.2019.377-386